1 results match your criteria: "Tumor hospital Chinese Academy of Medical Sciences[Affiliation]"
[Clinical Research of EGFR and KRAS Mutation in Fine Needle Aspiration Cytology Specimens of Non-small Cell Lung Carcinoma].
Zhongguo Fei Ai Za Zhi
April 2015
Department of Pathology, Tumor hospital Chinese Academy of Medical Sciences, Beijing 100021, China.
Article Synopsis
- The study focuses on the importance of detecting EGFR and KRAS mutations in lung cancer patients before starting targeted drug therapy.
- Using Real-time PCR on fine needle aspiration cytology samples from metastasized lymph nodes, researchers found an EGFR mutation rate of 37.3% and KRAS mutation rate of 7.2%.
- Clinical follow-up showed that patients with identified mutations responded well to treatment, with a significant portion achieving complete or partial remission.